Cargando…

Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022. Further information about the Annual Update in Intensive Care and Emergency Med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sauer, Andrea, Putensen, Christian, Bode, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951664/ https://www.ncbi.nlm.nih.gov/pubmed/35337355 http://dx.doi.org/10.1186/s13054-022-03909-1

Ejemplares similares

Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
por: Sauer, Andrea, et al.
Publicado: (2021)

Immunomodulation in the critically ill
por: Webster, N.R., et al.
Publicado: (2009)

Tetracycline ameliorates silica-induced pulmonary inflammation and fibrosis via inhibition of caspase-1
por: Peukert, Konrad, et al.
Publicado: (2022)

Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options—A Critical Review of the Evidence
por: Chastain, Daniel B, et al.
Publicado: (2020)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

Percutaneous and surgical tracheostomy in critically ill adult patients: a meta-analysis
por: Putensen, Christian, et al.
Publicado: (2014)

Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections
por: Richter, Enrico, et al.
Publicado: (2021)

Plant Derived Immunomodulators; A Critical Review
por: Swaroop, Akey Krishna, et al.
Publicado: (2022)

Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?
por: Plock, Jan A., et al.
Publicado: (2013)

Targeting circulating high mobility group box-1 and histones by extracorporeal blood purification as an immunomodulation strategy against critical illnesses
por: Li, Yupei, et al.
Publicado: (2023)

Emerging Electrochemical Sensors for Real-Time Detection of Tetracyclines in Milk
por: Raykova, Magdalena R., et al.
Publicado: (2021)

Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation
por: Schijns, Virgil, et al.
Publicado: (2021)

Tetracyclines in malaria
por: Gaillard, Tiphaine, et al.
Publicado: (2015)

Tetracycline Allergy
por: Hamilton, Leslie A., et al.
Publicado: (2019)

Skin Immunomodulation during Regeneration: Emerging New Targets
por: Mazini, Loubna, et al.
Publicado: (2021)

Highlights of Immunomodulation in Salmonella-Based Cancer Therapy
por: Pangilinan, Christian R., et al.
Publicado: (2021)

Payment options: do they affect outcome in the critically ill
por: Kar, A, et al.
Publicado: (2015)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

Emerging treatment options for nasopharyngeal carcinoma
por: Zhang, Lu, et al.
Publicado: (2013)

Serum chloride levels in critical illness—the hidden story
por: Pfortmueller, Carmen Andrea, et al.
Publicado: (2018)

Effect of Immune-Enhancing Enteral Nutrition Enriched with or without Beta-Glucan on Immunomodulation in Critically Ill Patients
por: Lee, Jae Gil, et al.
Publicado: (2016)

Boarding of Critically Ill Patients in the Emergency Department
por: Mohr, Nicholas M., et al.
Publicado: (2020)

Adjuvant therapeutic plasma exchange in septic shock
por: David, Sascha, et al.
Publicado: (2021)

Iron Metabolism: An Emerging Therapeutic Target in Critical Illness
por: Litton, Edward, et al.
Publicado: (2019)

Metabolomics: An emerging potential approach to decipher critical illnesses
por: Siddiqui, Mohd Adnan, et al.
Publicado: (2020)

Iron as an emerging therapeutic target in critically ill patients
por: Grange, Coralie, et al.
Publicado: (2023)

Drug-resistant tuberculosis: emerging treatment options
por: Adhvaryu, Meghna, et al.
Publicado: (2011)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Emerging treatment options for early mycosis fungoides
por: Fernandez-Guarino, Montserrat
Publicado: (2013)

Current and emerging treatment options for Peyronie’s disease
por: Gokce, Ahmet, et al.
Publicado: (2013)

Current and emerging treatment options for uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2013)

Emerging treatment options for meibomian gland dysfunction
por: Qiao, Jing, et al.
Publicado: (2013)

Birdshot uveitis: current and emerging treatment options
por: Menezo, Victor, et al.
Publicado: (2014)

Current and emerging treatment options for nasopharyngeal carcinoma
por: Spratt, Daniel E, et al.
Publicado: (2012)

Acquired hemophilia A: emerging treatment options
por: Janbain, Maissaa, et al.
Publicado: (2015)

Emerging treatment options for myelofibrosis: focus on pacritinib
por: Chow, Vivian, et al.
Publicado: (2016)

Chemophototherapy: An Emerging Treatment Option for Solid Tumors
por: Luo, Dandan, et al.
Publicado: (2016)

Emerging options for the treatment of melanoma – focus on ipilimumab
por: Roddie, Claire, et al.
Publicado: (2014)

Current and emerging treatment options in the management of lupus
por: Jordan, Natasha, et al.
Publicado: (2016)

Emerging treatment options for the management of pemphigus vulgaris
por: Kridin, Khalaf
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_01vsji93uoo8rbmgm409sks5gg